ATE292974T1 - Arsentrioxidfreie arsensulfidverbindungen zur behandlung von hämatologischen tumoren - Google Patents

Arsentrioxidfreie arsensulfidverbindungen zur behandlung von hämatologischen tumoren

Info

Publication number
ATE292974T1
ATE292974T1 AT98930630T AT98930630T ATE292974T1 AT E292974 T1 ATE292974 T1 AT E292974T1 AT 98930630 T AT98930630 T AT 98930630T AT 98930630 T AT98930630 T AT 98930630T AT E292974 T1 ATE292974 T1 AT E292974T1
Authority
AT
Austria
Prior art keywords
arsentic
rioxide
treatment
arsenic sulfide
sulfide compounds
Prior art date
Application number
AT98930630T
Other languages
English (en)
Inventor
Daopei Lu
Original Assignee
Daopei Lu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daopei Lu filed Critical Daopei Lu
Application granted granted Critical
Publication of ATE292974T1 publication Critical patent/ATE292974T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Treating Waste Gases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Iron (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicines Containing Plant Substances (AREA)
AT98930630T 1998-04-24 1998-07-06 Arsentrioxidfreie arsensulfidverbindungen zur behandlung von hämatologischen tumoren ATE292974T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN98101635A CN1233476A (zh) 1998-04-24 1998-04-24 治疗急性白血病的药物及其制备方法
PCT/CN1998/000118 WO1999055344A1 (en) 1998-04-24 1998-07-06 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies

Publications (1)

Publication Number Publication Date
ATE292974T1 true ATE292974T1 (de) 2005-04-15

Family

ID=5216829

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930630T ATE292974T1 (de) 1998-04-24 1998-07-06 Arsentrioxidfreie arsensulfidverbindungen zur behandlung von hämatologischen tumoren

Country Status (18)

Country Link
US (2) US6733792B1 (de)
EP (2) EP1552841A1 (de)
JP (1) JP2002512967A (de)
KR (1) KR100610388B1 (de)
CN (2) CN1233476A (de)
AT (1) ATE292974T1 (de)
AU (1) AU748795B2 (de)
BR (1) BR9815825A (de)
CA (1) CA2328165A1 (de)
DE (1) DE69829782T2 (de)
ES (1) ES2242286T3 (de)
ID (1) ID27299A (de)
IL (1) IL139208A (de)
NO (1) NO20005315D0 (de)
NZ (2) NZ508240A (de)
PL (1) PL344410A1 (de)
TR (1) TR200003117T2 (de)
WO (1) WO1999055344A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1391206B1 (de) 1997-10-15 2008-07-02 Polarx Biopharmaceuticals, Inc. Pharmazeutische Zusammensetzungen enthaltend Arsentrioxid zur Behandlung von nicht-Hodgkihn-Lymphome
IL136051A0 (en) * 1997-11-10 2001-05-20 Sloan Kettering Inst Cancer Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
FR2781674B1 (fr) * 1998-07-31 2002-06-28 Inst Nat Sante Rech Med Utilisation de nouveaux agents inducteurs de mort cellulaire en synergie avec les interferons
AUPQ296799A0 (en) 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
US7122632B2 (en) * 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
AUPR379801A0 (en) 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis
AUPR874601A0 (en) 2001-11-08 2001-11-29 Unisearch Limited Selective targeting of apoptotic cells
JP4571408B2 (ja) 2002-01-07 2010-10-27 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム 癌治療薬としての、s−ジメチルアルシノ−チオコハク酸、s−ジメチルアルシノ−2−チオ安息香酸、s−(ジメチルアルシノ)グルタチオン
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
US20030235571A1 (en) * 2002-06-19 2003-12-25 Gabriel Gojon-Romanillos Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
JP4426456B2 (ja) 2002-11-07 2010-03-03 ニューサウス イノベイションズ ピーティーワイ リミテッド ミトコンドリア膜透過性遷移の誘導
ES2428358T3 (es) * 2003-10-17 2013-11-07 Novo Nordisk A/S Terapia de combinación
TWI411431B (zh) * 2004-07-16 2013-10-11 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
EP1721615A1 (de) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmazeutische Zusammensetzung enthaltend Natrium- oder Kaliumarsenit zur Behandlung von Urogenitalkrebs und seinen Metastasen
ES2532666T3 (es) 2005-07-29 2015-03-30 Solasia Pharma K.K. Compuestos y métodos para el tratamiento del cáncer
US20070134349A1 (en) * 2005-09-19 2007-06-14 Duke University Methods of treating hematological malignancies
US20080233207A1 (en) * 2006-01-04 2008-09-25 Sheptovitsky Yelena G Injectable and Infusable Mercury Compositions and Methods for Treating Cancer
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
WO2008052279A1 (en) 2006-11-01 2008-05-08 Newsouth Innovations Pty Limited Organo-arsenoxide compounds and use thereof
CN101903029B (zh) * 2007-11-02 2012-09-26 Zio医药肿瘤学公司 使用有机砷化物的联合治疗
BRPI0821002A2 (pt) * 2007-12-12 2015-06-16 Ziopharm Oncology Inc Compostos e métodos para o tratamento de câncer
CA2734650A1 (en) 2008-08-20 2010-02-25 Ziopharm Oncology, Inc. Organoarsenic compounds and methods for the treatment of cancer
PL2475362T3 (pl) * 2009-09-10 2019-09-30 Kominox, Inc. Terapia celowana w nowotworowe komórki macierzyste i raka lekoopornego
SI3409289T1 (sl) 2010-02-26 2020-12-31 Novo Nordisk A/S Stabilni sestavki, ki vsebujejo protitelo
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
FR3004949B1 (fr) * 2013-04-26 2016-02-05 Centre Nat Rech Scient Traitement de maladies autoimmunes et inflammatoires par les composes de l'arsenic as203 et/ou as205 administres par voie locale
CN104434971A (zh) * 2014-02-28 2015-03-25 贺鹏程 一种用于治疗急性早幼粒细胞白血病的复方制剂、及其药物组合物、应用和制备方法
CN113491710A (zh) * 2017-02-24 2021-10-12 四川兴科蓉药业有限责任公司 β-As4S4在制备用于治疗血液系统恶性肿瘤的药物中的用途
WO2019134070A1 (en) * 2018-01-02 2019-07-11 Rui Jin Hospital, Shanghai Jiao Tong University School Of Medicine Panda as novel therapeutic
CN108338990A (zh) * 2018-04-11 2018-07-31 中国医学科学院基础医学研究所 水溶性雄黄固体分散体在制备骨髓造血干/祖细胞红系分化诱导剂中的应用
CN109528646A (zh) * 2018-11-21 2019-03-29 南京泽恒医药技术开发有限公司 一种巯嘌呤混悬液及其制备方法
CN110101713A (zh) * 2019-05-16 2019-08-09 上海交通大学医学院附属第九人民医院 一种三氧化二砷组合物的应用
CA3138472C (en) * 2019-05-21 2024-05-07 Medsenic Use of metal ions to potentiate the therapeutic effects of arsenic
CN112870225B (zh) * 2021-02-05 2023-01-06 北京大学人民医院 一种用于高危急性早幼粒细胞白血病诱导期的联合治疗药物
CN116338184B (zh) * 2023-04-24 2025-09-16 峰春源医疗器械(深圳)有限公司 一种高安全性新冠病毒抗原检测试剂盒
NL2039297B1 (en) * 2024-12-11 2025-07-18 Inst Chinese Materia Medica China Academy Of Cms Application of Realgar in the Preparation of Drugs for The Prevention and/or Treatment of Acute Promyelocytic Leukemia

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US132275A (en) 1872-10-15 Improvement in medical compounds
US232807A (en) 1880-10-05 Herbert e
US3700498A (en) 1970-12-10 1972-10-24 Ibm Process for making electrophotographic plates
JPS5129726A (de) 1974-09-06 1976-03-13 Mitsubishi Heavy Ind Ltd
JPS5188620A (en) 1975-01-31 1976-08-03 Jintainokenkonoiji kotonigannitaishitekonoojusuru noshukuionekinoseizoho
DE3003635C2 (de) 1980-02-01 1985-07-11 Klöckner-Humboldt-Deutz AG, 5000 Köln Verfahren und Vorrichtung zur Entarsenierung arsenhaltiger Materialien
FR2539993A1 (fr) 1983-01-28 1984-08-03 Darcheux Mario Baume agissant sur les plaies cancereuses
GB2226494B (en) * 1988-07-20 1991-10-09 Poon Theodore Man Photosynthesis in men's blood to cure cancer-part 2 phmd(cancer)
US5759837A (en) 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
CN1061908A (zh) * 1991-12-21 1992-06-17 江西省妇产医院 一种治癌药物的制造方法
CN1060935C (zh) 1992-05-31 2001-01-24 丛繁滋 用于癌病灶直接给药的砷制剂的制备方法
CN1044777C (zh) 1992-07-06 1999-08-25 杨世泽 癌痛止痛膏的配制方法
ES2183815T3 (es) 1992-07-24 2003-04-01 Univ Johns Hopkins Quimioterapia para el cancer.
DE4317331A1 (de) 1993-05-25 1994-12-01 Reischle Karl Georg Behandlung von Schädigungen des Immunsystems
ITTO930510A1 (it) 1993-07-09 1993-10-07 Walter Tarello Farmaci attivi contro la chronic fatigue syndrome (c.f.s.)
EP0804928B1 (de) 1994-02-18 2004-10-20 Tamara Vasilievna Vorobieva Substanz mit immunonodulierender wirkung und zur verringerung der disfunktion des gewebezellenregelungssystems
CN1119113A (zh) 1994-09-22 1996-03-27 衣永德 复方癌复康胶囊及制备方法
CN1122700A (zh) 1994-11-08 1996-05-22 付知中 一种治疗乳腺疾病、肿瘤疮毒的散剂及其制备方法
LV11667B (en) 1995-08-14 1997-06-20 Tamara Vorobieva Remedy for renewal of disordered function of immunomodulation and cell tissue reproduction adjustors
CN1044559C (zh) 1995-08-23 1999-08-11 哈尔滨医科大学附属第一医院 抗白血病、肝癌、淋巴瘤注射液
CN1058620C (zh) 1995-11-12 2000-11-22 卢颖 一种治疗癌症的外用中成药及配备生产工艺
CN1052648C (zh) 1995-12-03 2000-05-24 唐书生 癌瘤消肿止痛膏
EP1391206B1 (de) * 1997-10-15 2008-07-02 Polarx Biopharmaceuticals, Inc. Pharmazeutische Zusammensetzungen enthaltend Arsentrioxid zur Behandlung von nicht-Hodgkihn-Lymphome
IL136051A0 (en) 1997-11-10 2001-05-20 Sloan Kettering Inst Cancer Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol

Also Published As

Publication number Publication date
EP1552841A1 (de) 2005-07-13
NO20005315L (no) 2000-10-20
IL139208A (en) 2005-08-31
DE69829782D1 (de) 2005-05-19
IL139208A0 (en) 2001-11-25
ID27299A (id) 2001-03-22
DE69829782T2 (de) 2006-03-09
KR100610388B1 (ko) 2006-08-09
TR200003117T2 (tr) 2001-03-21
NZ526746A (en) 2005-01-28
AU748795B2 (en) 2002-06-13
CA2328165A1 (en) 1999-11-04
HK1034466A1 (en) 2001-10-26
US6733792B1 (en) 2004-05-11
NO20005315D0 (no) 2000-10-20
JP2002512967A (ja) 2002-05-08
ES2242286T3 (es) 2005-11-01
NZ508240A (en) 2003-08-29
US20040028750A1 (en) 2004-02-12
US7138147B2 (en) 2006-11-21
PL344410A1 (en) 2001-11-05
EP1077709A4 (de) 2002-06-19
AU8100998A (en) 1999-11-16
CN1299284A (zh) 2001-06-13
BR9815825A (pt) 2000-12-12
KR20010071160A (ko) 2001-07-28
CN1175823C (zh) 2004-11-17
EP1077709B1 (de) 2005-04-13
WO1999055344A1 (en) 1999-11-04
EP1077709A1 (de) 2001-02-28
CN1233476A (zh) 1999-11-03

Similar Documents

Publication Publication Date Title
DE69829782D1 (de) Arsentrioxidfreie arsensulfidverbindungen zur behandlung von hämatologischen tumoren
AU652155B2 (en) Diebenzoylalkylcyanohydrazines
ATE407683T1 (de) Pharmazeutische zusammensetzungen enthaltend arsentrioxid zur behandlung von multiplen myelom
DK176185D0 (da) Stabiliserede klaebestoffer
PE14199A1 (es) Agonistas de 5-ht1f
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
ATE273364T1 (de) Zusammensetzungen zur stabilisierung von sauerstoffempfindlichen verbindungen
DE60214359D1 (en) Stickstoffbasierte camptothecin-derivate
ATE271390T1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
ATE380816T1 (de) Substituierte imidazopyrimidine zur prävention und behandlung von krebs
FR2831534B1 (fr) Composition photoactivable et utilisations
DE69617005D1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
AU2003300385A8 (en) Anticancer compounds
EA200301126A1 (ru) Противоопухолевая композиция, содержащая толуолсульфонамид, и способ ее применения
DE60335980D1 (de) Verfahren zur herstellung von synthetischen derivaten von dibenzylbutyrolacton-lignanen mit antichagas eigenschaften
DE50108711D1 (de) Verwendung von substituierten 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
MX9303643A (es) Procedimiento para la fabricacion de fibras de poli(sulfuro de arileno) y multifilamentos de poli(sulfuro de arinelo) obtenibles segun dicho procedimiento.
ATE323690T1 (de) Bicyclische(3.1.0)hexane und verwandte verbindungen
ATE552851T1 (de) Zusammensetzungen zur behandlung von brust- und bauchspeicheldrüsenkrebs
DE60305520D1 (de) 2" oxo-voruscharin und derivaten
WO2003038114A3 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 86604

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties